Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

http://www.wikidata.org/entity/Q24609544

about

The spectrum of SWI/SNF mutations, ubiquitous in human cancers SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes A landscape of driver mutations in melanoma ARID2: a new tumor suppressor gene in hepatocellular carcinoma Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas Hepatocellular carcinoma: Where are we?Epigenetic modulators, modifiers and mediators in cancer aetiology and progression Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics The mutational landscape of hepatocellular carcinoma Minireview: Conversing with chromatin: the language of nuclear receptors Epigenetics in liver disease SWI/SNF chromatin remodeling complexes and cancer The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions Emerging patterns of somatic mutations in cancer Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma Genetic alterations in hepatocellular carcinoma: An update Epigenetics in liver disease: from biology to therapeutics SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2 Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes ARID1A mutations in cancer: another epigenetic tumor suppressor?BAF200 is required for heart morphogenesis and coronary artery development Chd5 requires PHD-mediated histone 3 binding for tumor suppression Comparison of hepatocellular carcinoma in Eastern versus Western populations.Biomarkers of genome instability and cancer epigenetics.Genomic profiling reveals mutational landscape in parathyroid carcinomas Impact of the next-generation sequencing data depth on various biological result inferences.Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53 Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.Integrated analysis of recurrent properties of cancer genes to identify novel drivers Genomic profile analysis of diffuse-type gastric cancers Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.Screening for inhibitors of an essential chromatin remodeler in mouse embryonic stem cells by monitoring transcriptional regulation.

P2860

Q21090801-751FF798-E09C-4DDB-8DEA-8EE9B3C4E021 Q21134718-055AAF7D-DEC0-41DF-8527-5AC3525C6A7D Q24596715-2ECF33EA-ACC3-4405-8F5D-07508163881D Q24603357-E5543065-FD19-453C-A051-C5187685F8B4 Q24607045-C7004CB8-0BE9-4414-B15A-26B2F7AC920B Q24607661-FC7243EC-5C17-4059-AFBA-A8CB4B98E8B1 Q24619351-8B7D6AF8-2CEB-4845-9019-E9B33B2375D0 Q26745338-599A1D09-7F60-4562-8CA4-D07902435200 Q26751724-03F9CF16-765D-4C10-BC47-09D6190D3587 Q26765182-0DE5FC50-262E-40EE-BD95-491DC6523401 Q26766149-FCDB4839-5A14-4B27-98C3-9B6F43D63401 Q26766689-5AE7C6A1-F1AD-4D62-A453-E72899DD5B9D Q26776098-576602FA-1D8B-4CB9-AB6F-95B0404C1236 Q26777478-240B96C5-9350-4E10-958E-78771B1E1445 Q26829103-901B4EA2-DDA3-4777-A9E3-90D5F24DADB9 Q26849263-2B17C1FC-9FC2-4B8F-9444-64EFC7E05B32 Q26998657-F11AAD62-9B3C-4C4E-8D57-D25FC1CEFE91 Q27003050-E2E6D511-C597-4D3F-B546-92F43EFBD114 Q27009284-1F0C88FB-F0C4-453A-9ECA-199BB426E563 Q27014126-3D2A4797-9081-40AE-AD94-FAB2AB3CE24D Q27026846-EFE2C477-3A7E-4DB5-86AE-2B1540D6457D Q28073241-F1DAA7AC-EB7D-4D39-A881-E9599DC58261 Q28079271-06CBDBE7-BC77-4E86-872B-70D960E107E8 Q28269618-5C1B533E-CB57-4D73-A7A0-5E2761BBED60 Q28271584-9F421011-DAA4-47CD-863B-8B9BCEE22483 Q28280605-00C58762-CE57-48A5-9AF4-A29EC1AC5730 Q28510974-17C00D69-E288-4E89-8D72-6E743E056826 Q28593132-5DF4CD60-39F7-44B2-89E7-C52E790AE53C Q30245396-0079F3A3-8B95-4A8A-AECA-E3767E350377 Q30248745-A76BE54D-EC90-4962-928D-0ACC29DC598F Q30360213-1D56368C-9B07-4B6D-9D78-845D9BBC66DB Q30587393-87424C79-0A92-4AEB-9062-244542D1DBFF Q30834745-0EC01A7C-0650-4724-B87B-F6F01DA68D4C Q33663060-442F16CF-7C8C-4968-80F6-59E5F7E55694 Q33688583-A898A1B2-D6AF-4550-9D38-F785818368B6 Q33742981-ECD2C061-14D1-49C7-A96F-0C3592B1E229 Q33751124-36798841-1F8E-46B1-9E20-C9524ACC50B2 Q33833557-DA6EB3AD-429F-4563-B52F-C00F731BC695 Q33873291-120AA07B-42D6-45D2-9C6B-021B7E675830 Q33898400-BB6BD57B-9059-47C8-BFD1-998BD0B6006F

P2860

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

http://www.wikidata.org/entity/Q24609544

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@ast

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@en

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@nl

type

label

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@ast

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@en

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@nl

prefLabel

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@ast

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@en

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@nl

P1433

Q24609544-99873E5C-7C17-41D6-8782-55983C6CB140

P1476

Q24609544-D0A19C21-E0DC-481F-A8DE-A9B26EACA088

P2093

Q24609544-11D1F124-0876-4F9B-8007-BF55A27B47E1

Q24609544-3284F837-F73C-485C-B409-4AA4D417C2D6

Q24609544-59F7A19C-3BAC-412A-8A89-82B2E5D1ADD6

Q24609544-6F779BD9-946F-4B38-9544-D71792B7887B

Q24609544-963B78E0-E278-461A-8F15-59D5AE4A17D6

Q24609544-A59F3B1E-7FBC-42C8-810A-4A36A60BE7F9

Q24609544-B8DC5AA5-0C05-4042-811A-9116707BD51F

Q24609544-BFB583C1-D43A-47B3-983E-8A5C018E83E4

Q24609544-C9AA1D90-CB44-4C6F-986B-E19E62AEBE45

Q24609544-E662564B-77C4-43CF-BD87-257EF128A5CE

P2860

Q24609544-08C2D1D6-A1CA-40F3-82F8-D5D4FE9F1510

Q24609544-16206773-ED3E-4BE9-9B09-0B2144EEB8F6

Q24609544-2052621A-34E9-4F8A-B822-307841D11B7E

Q24609544-21B01AF2-C6C7-4915-B37D-3A2C97D9AAA5

Q24609544-373E66ED-06D9-4777-B54C-E4204548C8E7

Q24609544-3863C5BA-FE46-4796-BF53-6D0049F3CFA6

Q24609544-55B87F01-99F0-4F9B-A8BC-985C90F6B7CF

Q24609544-595F04DD-6213-4529-92E2-EC803989B3D4

Q24609544-9AFB5E4E-8D8D-4CEA-A0BB-F4065AE40DCF

Q24609544-AF965E23-80E0-42A5-A52F-D5F0642FF738

P2888

Q24609544-0188A11F-48F5-43A2-85D2-BC39271A15DB

P304

Q24609544-D6662476-8618-43C0-9D7B-D4794308D7D1

P31

Q24609544-E9F5FB9F-920F-4FCD-9338-84FE8FD825AE

P3181

Q24609544-987D6AE0-3822-4972-BA3B-3EBBE3518EA4

P356

Q24609544-3F37A6D1-66CA-4DDC-BF26-49E0294BBBD8

P407

Q24609544-025D64AA-65FA-484F-87D9-0635F171AC6B

P433

Q24609544-2571F4B9-CE8D-4F4F-9A3A-7B65876B34F1

P478

Q24609544-0863A4F2-9B95-4709-9602-89C7FE512373

P50

Q24609544-5AD40577-B89C-4353-A3BB-1C93D6D872EE

Q24609544-A632D8B8-32B2-41A6-B63F-025A6533F562

Q24609544-C793E233-F2E8-44DA-9374-55C96E81B3CC

Q24609544-D33042F7-0827-4955-93C0-E32D005839CE

Q24609544-F464D2E0-D5CB-4B80-B5BE-3820E39C16B6

P577

Q24609544-F9BF6E6A-2EB4-4353-B3A0-6913BAF08C61

P5875

Q24609544-DEB50891-358E-4571-8BB6-E3E33A7C2AE9

P6179

Q24609544-08D58E2D-EB5D-48E3-880C-3F38F3A77835

P698

Q24609544-AD543F10-E99D-4732-875E-2791EA928105

P932

Q24609544-B7D8A9EB-3D1C-4BD7-BE57-B95EE103AEFD

P3181

P356

P1433

Nature Genetics

P1476

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

@en

P2093

G Johan A Offerhaus

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Hubert D Daniel

http://www.w3.org/2001/XMLSchema#string

Jianqiang Cai

http://www.w3.org/2001/XMLSchema#string

Laura D Wood

http://www.w3.org/2001/XMLSchema#string

Linfang Wang

http://www.w3.org/2001/XMLSchema#string

Meng Li

http://www.w3.org/2001/XMLSchema#string

Michael A Choti

http://www.w3.org/2001/XMLSchema#string

Michael S Torbenson

http://www.w3.org/2001/XMLSchema#string

Nick Papadopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain

PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes.

Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes

ARID1A mutations in endometriosis-associated ovarian carcinomas

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

Cancer genes and the pathways they control

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Hepatocellular carcinoma pathogenesis: from genes to environment

Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.

P2888

P304

828-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1676310

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.903

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Kenneth W Kinzler

Victor Velculescu

Bert Vogelstein

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51552718

http://www.w3.org/2001/XMLSchema#string

P6179

1018806881

http://www.w3.org/2001/XMLSchema#string

P698

21822264

http://www.w3.org/2001/XMLSchema#string

P932

3163746

http://www.w3.org/2001/XMLSchema#string